corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Updates

Update 2007-03-29

ADWATCH: GSK AVANDIA
Do not ADOPT rosiglitazone as first-line diabetes treatment.
www.healthyskepticism.org/global/adwatch/issue/au2007-03


HEALTHY SKEPTICISM INTERNATIONAL NEWS
February 2007 Vol 25 No 2
What everyone needs to know about drug marketing. Part 3: Place, Promotion and Goals
By: Peter R Mansfield
This is the final part of a three part article about drug promotion.
www.healthyskepticism.org/global/news/issue/hsin07-02


MEDICINS SANS FRONTIERES PETITION: ASK NOVARTIS TO DROP CASE AGAINST INDIA
Novartis is taking the Indian government to court. If Novartis is successful in its challenge against the Indian government and its patent law, more medicines are likely to be patented in India, making it very difficult for generic producers to make affordable versions of them. This could affect millions of people around the world who depend on medicines produced in India. Please sign the petition:
http://web.archive.org/web/20090122074056/http://www.msf.org/petition_india/international.html *


RECOMMENDED WEBSITES
When we hear about relevant websites that are new or new to us we list them in our What’s New forum:
[obsolete URL deleted]

The best of the new websites include:

PharmedOut
An independent project run by physicians for physicians and other prescribers. The goal is to disseminate information about how pharmaceutical companies influence what we prescribe, to increase access to unbiased information about drugs, and to encourage physicians to choose pharma-free CME.
www.pharmedout.org

Hooked: Ethics, Medicine, and Pharma
Updates and Commentary related to the book “Hooked: Ethics, the medical profession and the pharmaceutical industry” by Howard Brody, MD, PhD ( Rowman and Littlefield, January, 2007 )
http://brodyhooked.blogspot.com

Pharmalot
Pharmalot’s self description is “a home for lively discussion about news and trends in the pharmaceutical industry. This blog is written by Ed Silverman, a veteran journalist for The Star-Ledger of New Jersey.
http://pharmalot.com

We will introduce more websites in a later issue of Healthy Skepticism Updates.

 

Updates homepage

 

Comments

Our members can see and make comments on this page.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

  • E-mail
  • LinkedIn
  • Del.icio.us
  • Digg
  • Facebook
  • FriendFeed
  • Google Bookmarks
  • MySpace
  • Reddit
  • Slashdot
  • StumbleUpon
  • Tumblr
  • Twitter
  • Yahoo! Bookmarks



Next Update: Update 2007-04-25

Previous Update: Update 2007-03-19

Updates homepage






...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.